Close Menu

NEW YORK – Laboratory Corporation of America has received US Food and Drug Administration Emergency Use Authorization permitting home self-collection of samples for its COVID-19 RT-PCR test.

The FDA said separately that it was reissuing the EUA to LabCorp to allow for the self-collection of samples by patients. It is the first EUA issued by the agency for a SARS-CoV-2 test using at-home self-collection, it added.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.